| scholarly article | Q13442814 |
| P2093 | author name string | Xing-Dong Zhang | |
| Hai-Yan Liu | |||
| Xin-Jie Bao | |||
| Yun-Bao Guo | |||
| Song-Bai Xu | |||
| P2860 | cites work | Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo | Q28180577 |
| Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production | Q28185379 | ||
| Mitotic kinases as regulators of cell division and its checkpoints | Q28202545 | ||
| Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function | Q28246944 | ||
| Therapeutic applications of compounds in the Magnolia family | Q28304238 | ||
| p53-dependent apoptosis in melanoma cells after treatment with camptothecin | Q28371768 | ||
| Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells | Q28478749 | ||
| The cell cycle-regulated protein human GTSE-1 controls DNA damage-induced apoptosis by affecting p53 function. | Q34197362 | ||
| Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation | Q34734168 | ||
| Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway | Q35063895 | ||
| Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death | Q35068689 | ||
| Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases. | Q35448249 | ||
| Jaridonin-induced G2/M phase arrest in human esophageal cancer cells is caused by reactive oxygen species-dependent Cdc2-tyr15 phosphorylation via ATM-Chk1/2-Cdc25C pathway | Q36486960 | ||
| Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. | Q36496451 | ||
| The natural product honokiol inhibits calcineurin inhibitor-induced and Ras-mediated tumor promoting pathways | Q37112443 | ||
| Cell cycle arrest and apoptotic induction in LNCaP cells by MCS-C2, novel cyclin-dependent kinase inhibitor, through p53/p21WAF1/CIP1 pathway | Q38510413 | ||
| CR389, a benzoimidazolyl pyridinone analog, induces cell cycle arrest and apoptosis via p53 activation in human ovarian cancer PA-1 cells | Q38914442 | ||
| Deoxypodophyllotoxin induces G2/M cell cycle arrest and apoptosis in SGC-7901 cells and inhibits tumor growth in vivo | Q38917846 | ||
| Knockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells | Q38936969 | ||
| The mechanism of honokiol-induced intracellular Ca(2+) rises and apoptosis in human glioblastoma cells | Q38967800 | ||
| Expression of survivin and p53 modulates honokiol-induced apoptosis in colorectal cancer cells | Q38987655 | ||
| Honokiol inhibits U87MG human glioblastoma cell invasion through endothelial cells by regulating membrane permeability and the epithelial-mesenchymal transition | Q39061712 | ||
| In vitro growth inhibition of human cancer cells by novel honokiol analogs | Q39358757 | ||
| Gossypin induces G2/M arrest in human malignant glioma U251 cells by the activation of Chk1/Cdc25C pathway | Q39460930 | ||
| Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress | Q39780862 | ||
| Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells | Q39896830 | ||
| Inhibition of Hsp90 function by ansamycins causes downregulation of cdc2 and cdc25c and G(2)/M arrest in glioblastoma cell lines. | Q40127963 | ||
| Honokiol inhibits the progression of collagen-induced arthritis by reducing levels of pro-inflammatory cytokines and matrix metalloproteinases and blocking oxidative tissue damage | Q42940156 | ||
| Oligosaccharide G19 inhibits U-87 MG human glioma cells growth in vitro and in vivo by targeting epidermal growth factor (EGF) and activating p53/p21 signaling | Q46897628 | ||
| Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice | Q47894985 | ||
| p53-dependent pathways of apoptosis | Q77099494 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 7168-7175 | |
| P577 | publication date | 2015-05-15 | |
| P1433 | published in | International Journal of Clinical and Experimental Medicine | Q6051338 |
| P1476 | title | Honokiol induces cell cycle arrest and apoptosis via p53 activation in H4 human neuroglioma cells | |
| P478 | volume | 8 |
| Q33919087 | Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth |
| Q47962641 | Honokiol protects skin cells against inflammation, collagenolysis, apoptosis, and senescence caused by cigarette smoke damage |
| Q64980315 | The activation of BDNF reduced inflammation in a spinal cord injury model by TrkB/p38 MAPK signaling. |
Search more.